These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1771827)

  • 41. Effects of the common protective antigen (OEP) and toxoids of protease and elastase from Pseudomonas aeruginosa on protection against hemorrhagic pneumonia in mink.
    Honda E; Homma JY; Abe C; Tanamoto K; Noda H; Yanagawa R
    Zentralbl Bakteriol Orig A; 1977; 237(2-3):297-309. PubMed ID: 403712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
    Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multivalent DNA vaccine protects mice against pulmonary infection caused by Pseudomonas aeruginosa.
    Saha S; Takeshita F; Sasaki S; Matsuda T; Tanaka T; Tozuka M; Takase K; Matsumoto T; Okuda K; Ishii N; Yamaguchi K; Klinman DM; Xin KQ; Okuda K
    Vaccine; 2006 Sep; 24(37-39):6240-9. PubMed ID: 16806598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
    Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Antigenic complexes of Pseudomonas aeruginosa slime: their isolation and biological properties].
    Aleksandrov AD; Antsiferova NG; Zhmyrina TI; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):14-9. PubMed ID: 6422680
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia.
    Pennington JE; Pier GB; Sadoff JC; Small GJ
    Rev Infect Dis; 1986; 8 Suppl 4():S426-33. PubMed ID: 2944209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Experimental chronic Pseudomonas aeruginosa lung infection in rats. Non-specific stimulation with LPS reduces lethality as efficiently as specific immunization.
    Lange KH; Hougen HP; Høiby N; Fomsgaard A; Rygaard J; Johansen HK
    APMIS; 1995 May; 103(5):367-74. PubMed ID: 7654361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Protective properties of antigenic preparations of Pseudomonas aeruginosa].
    Grishina IA; Kolker II; Stanislavskiĭ ES; Zhvanetskaia MI; Palkina MI
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Jun; (6):63-7. PubMed ID: 6778029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice.
    Holder IA; Neely AN; Frank DW
    Infect Immun; 2001 Sep; 69(9):5908-10. PubMed ID: 11500471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Experimental study of the protective activity of vaccines made from 7 Pseudomonas aeruginosa immunotypes].
    Kholodkova EV; Fedotova IuM; Stanislavskiĭ ES
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):47-50. PubMed ID: 2446445
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Immunoprophylaxis and immunotherapy of infection caused by Pseudomonas aeruginosa: research results and prospects].
    Stanislavskiĭ ES; Joó I
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jul; (7):22-31. PubMed ID: 6414198
    [No Abstract]   [Full Text] [Related]  

  • 52. 40 years on: have we finally got a vaccine for Pseudomonas aeruginosa?
    Worgall S
    Future Microbiol; 2012 Dec; 7(12):1333-5. PubMed ID: 23231481
    [No Abstract]   [Full Text] [Related]  

  • 53. [Principle of constructing polyvalent Pseudomonas aeruginosa vaccines].
    Akatova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Feb; (2):56-60. PubMed ID: 84457
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Derivation and experimental evaluation of polyvalent corpuscular vaccine for prevention of infections caused by Pseudomonas aeruginosa. I. Development of polyvalent corpuscular vaccine].
    Moroz AF; Radkevich SA; Antsiferova NG; Brodinova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1981; (8):44-9. PubMed ID: 6171956
    [No Abstract]   [Full Text] [Related]  

  • 55. The first clinical trial of immuno's experimental Pseudomonas aeruginosa flagellar vaccines.
    Crowe BA; Enzersberger O; Schober-Bendixen S; Mitterer A; Mundt W; Livey I; Pabst H; Kaeser R; Eibl M; Eibl J
    Antibiot Chemother (1971); 1991; 44():143-56. PubMed ID: 1801633
    [No Abstract]   [Full Text] [Related]  

  • 56. Active immunization of burned patients with a new multivalent Staphylococcus-Pseudomonas vaccine.
    Sachs A
    Prog Immunobiol Stand; 1971; 5():428-32. PubMed ID: 4633971
    [No Abstract]   [Full Text] [Related]  

  • 57. R-form lipopolysaccharides (LPS) of Gram-negative bacteria as possible vaccine antigens.
    Stanislavsky ES; Makarenko TA; Kholodkova EV; Lugowski C
    FEMS Immunol Med Microbiol; 1997 Jul; 18(3):139-45. PubMed ID: 9271164
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pseudomonas aeruginosa vaccines, past and present].
    Takigami T
    Nihon Rinsho; 1991 Oct; 49(10):2410-5. PubMed ID: 1684215
    [No Abstract]   [Full Text] [Related]  

  • 59. Progress in immunization against Pseudomonas aeruginosa and Klebsiella spp.
    Cryz SJ
    Pathol Immunopathol Res; 1987; 6(2):147-52. PubMed ID: 3122194
    [No Abstract]   [Full Text] [Related]  

  • 60. Induction of protective immune response by vaccination against Pseudomonas pneumonia of mink.
    Elsheikh LE; Karlsson KA; Bergman R; Abaas S
    Zentralbl Veterinarmed B; 1988 May; 35(4):256-63. PubMed ID: 3138862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.